228 results on '"Iacopino, Pasquale"'
Search Results
2. Ontology Based Personalized Modeling for Type 2 Diabetes Risk Analysis: An Integrated Approach
3. Discovering Diagnostic Gene Targets and Early Diagnosis of Acute GVHD Using Methods of Computational Intelligence over Gene Expression Data
4. The costs of mobilisation and collection of peripheral blood stem cells in multiple myeloma and lymphoma in an European country: Results from The Gruppo Italiano Trapianto Midollo Osseo (GITMO) and Società Italiana di Emaferesi e Manipolazione Cellulare (SIdEM) survey
5. Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: A GITMO study
6. Advances in medical decision support systems for diagnosis of acute graft-versus-host disease: molecular and computational intelligence joint approaches
7. Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms
8. Changes in angiogenesis and hypoxia-inducible factor-1α protein expression in relapsed/refractory indolent non-Hodgkin lymphomas
9. Peg-filgrastim versus filgrastim after autologous stem cell tranplantation: Case-control study in patients with multiple myeloma and review of the literature
10. Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients
11. Machine Learning and Personalized Modeling Based Gene Selection for Acute GvHD Gene Expression Data Analysis
12. Different γ/δ T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation
13. Discovering Diagnostic Gene Targets and Early Diagnosis of Acute GVHD Using Methods of Computational Intelligence over Gene Expression Data
14. Ontology Based Personalized Modeling for Type 2 Diabetes Risk Analysis: An Integrated Approach
15. Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion
16. Absence of the V617F JAK2 Mutation in the Lymphoid Compartment in a Patient with Essential Thrombo- cythemia and B-Chronic Lymphocytic Leukemia and in Two Relatives with Lymphoproliferative Disorders
17. Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
18. Eosinophilic fasciitis associated with autoimmune phenomena after bone marrow transplantation: report of two cases
19. MDR1 polymorphism influences the outcome of multiple myeloma patients
20. WERNICKEʼS ENCEPHALOPATHY AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
21. UTILITY OF THE CLINICAL PRACTICE OF ADMNISTERING THROMBOPHILIC SCREENING AND ANTITHROMBOTIC PROPHYLAXIS WITH LOW-MOLECULAR-WEIGHT HEPARIN TO HEALTHY DONORS TREATED WITH G-CSF FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS
22. Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients
23. High-Dose Therapy and Autologous Peripheral Blood Stem Cells Transplantation Followed by a Very Low Reduced Intensity Regimen With Fludarabine + Cyclophosphamide and Allograft Improve Complete Remission Rate in De Novo Multiple Myeloma Patients
24. Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients
25. Harvesting Peripheral Blood Progenitor Cells From Healthy Donors: Retrospective Comparison of Filgrastim and Lenograstim
26. AUTOLOGOUS STEM CELL TRANSPLANTATION (AutoSCT) FOLLOWED BY A NON-MYELOABLATIVE CONDITIONING AND ALLOGENEIC STEM CELL TRANSPLANTATION (AlloSCT) AS CONSOLIDATION THERAPY FOR MULTIPLE MYELOMA (MM)
27. A STUDY OF FEASIBILITY AND TOXICITY OF MULTIPLE CYCLES OF HIGH-DOSE MELPHALAN (HDM) FOLLOWED BY AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (APBSCT) IN ELDERLY PATIENTS (PTS) WITH MULTIPLE MYELOMA (MM)
28. MOBILIZATION OF CD34+ CELLS BY GLYCOSYLATED AND NON-GLYCOSYLATED G-CSF IN HEALTHY DONORS: A COMPARATIVE STUDY
29. A TREATMENT WITH RECOMBINANT HUMAN ERYTHROPOETIN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION SIGNIFICANTLY REDUCES TRANSFUSION REQUIREMENT IN MULTIPLE MYELOMA PATIENTS
30. REPEATED COURSES OF HIGH-DOSE MELPHALAN (HDM) WITH SUPPORT OF PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (PBSCT) MAY IMPROVE PROGNOSIS IN PATIENTS AFFECTED BY MULTIPLE MYELOMA (MM)
31. EPIDEMIOLOGY OF ACUTE LEUKEMIA IN CALABRIA
32. INFECTIOUS COMPLICATIONS IN BREAST CANCER (BC) PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) AFTER HIGH DOSE CHEMOTHERAPY (HDC): A SINGLE CENTER RETROSPECTIVE ANALYSIS TOWARDS OUTPATIENT STRATEGY
33. AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) AFTER HIGH DOSE CHEMOTHERAPY (HDC) INFLUENCES THE OUTCOME OF PROGRESSION FREE (PFS) AND OVERALL SURVIVAL (OS) IN METASTATIC BREAST CANCER (MBC) PATIENTS CLASSIFIED ACCORDING TO A RISK GROUP SCORE
34. High-Dose Chemotherapy plus Hematopoietic Stem-Cell Rescue for Metastatic Breast Cancer
35. Surface CD14 positivity in B-cell chronic lymphocytic leukaemia is related to clinical outcome
36. In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemia
37. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia: results of an international multicenter randomized trial
38. Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia
39. High-dose chemotherapy plus hematopoietic stem-cell rescue for metastatic breast cancer
40. Autologous hematopoietic stem cell transplantation in multiple sclerosis: A phase II trial
41. Functions of T cells and recruitment of cellular response afterin vitro mitogenic stimulation of lymphocytes in chronic lymphocytic leukaemia
42. In vitro proliferative response of chronic lymphocytic leukemia: Behaviour of bone marrow, lymph node and peripheral blood lymphocytes and the effect of autologous serum on mitogen-induced reactivity
43. The predictive role of a�-double negative T cells in clinical outcome of patients with lymphoma: preliminary data of prospective study
44. Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma
45. SP109PRELIMINARY EVALUATION OF UNCONVENTIONAL T CELLS IN RENAL CELL CARCINOMA (RCC) PATIENTS
46. αβ-Double Negative CD4/CD8 (CD56) T cell (DNTs) in metastatic melanoma: basal frequency and behaviour during Ipilimumab treatment. Preliminary evaluations
47. Relevance of αβ-DNTs as Prognostic Factor on Clinical Outcome and Role on Tumor Surveillance in Haematological Diseases and Solid Tumor: Preliminary Evaluations
48. Cancer Associated Fibroblasts in Multiple Myeloma: The Urokinase Receptor System in Tumor Growth Regulation
49. I tumori e le emopatie in Calabria negli anni 1998-2001. La spesa ospedaliera per tumori in Calabria, Le sfide del futuro alla luce delle esperienze delle altre Regioni e dei Paesi Europei
50. Challenges and Opportunities of MicroRNAs in Lymphomas
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.